These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24175973)

  • 21. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of perindopril on aldosterone production in the failing human heart.
    Mizuno Y; Yasue H; Yoshimura M; Fujii H; Yamamoto N; Nakayama M; Harada E; Sakamoto T; Nakamura S; Ito T; Shimasaki Y; Ogawa H; Saito Y; Nakao K
    Am J Cardiol; 2002 May; 89(10):1197-200. PubMed ID: 12008175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME; Remme WJ; Fox KM; Ferrari R; Simoons ML;
    Int J Cardiol; 2007 Sep; 121(1):57-61. PubMed ID: 17270296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
    J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats.
    Duke LM; Paull JR; Widdop RE
    Clin Exp Pharmacol Physiol; 2003; 30(5-6):317-23. PubMed ID: 12859420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of perindopril on left ventricular structural and functional parameters in patients with preserved systolic function after myocardial infarction. Relation to polymorphism of angiotensin converting enzyme gene].
    Tereshchenko SN; Dzhaiani NA; Moiseev VS; Nosikov VV
    Kardiologiia; 2002; 42(5):38-41. PubMed ID: 12494147
    [No Abstract]   [Full Text] [Related]  

  • 29. Can the epirubicin cardiotoxicity in cancer patients be prevented by angiotensin converting enzyme inhibitors?
    Radulescu D; Buzdugan E; Ciuleanu TE; Todor N; Stoicescu L
    J BUON; 2013; 18(4):1052-7. PubMed ID: 24344038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
    van de Ven LL; van Veldhuisen DJ; Goulder M; Zilahi Z; Meyer WR; Willenheimer R
    Int J Cardiol; 2010 Sep; 144(1):59-63. PubMed ID: 19481278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving endothelial function and reducing remodeling post-MI are key to perindopril benefits in coronary artery disease.
    Cardiovasc J S Afr; 2006; 17(4):203-4. PubMed ID: 17001425
    [No Abstract]   [Full Text] [Related]  

  • 33. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
    J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
    Cavasin MA; Yang XP; Liu YH; Mehta D; Karumanchi R; Bulagannawar M; Carretero OA
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):472-80. PubMed ID: 11026648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity.
    Pituskin E; Mackey JR; Koshman S; Jassal D; Pitz M; Haykowsky MJ; Pagano JJ; Chow K; Thompson RB; Vos LJ; Ghosh S; Oudit GY; Ezekowitz JA; Paterson DI
    J Clin Oncol; 2017 Mar; 35(8):870-877. PubMed ID: 27893331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of perindopril on cardiac remodelling and prognostic value of pre-discharge quantitative echocardiographic parameters in elderly patients after acute myocardial infarction: the PREAMI echo sub-study.
    Nicolosi GL; Golcea S; Ceconi C; Parrinello G; Decarli A; Chiariello M; Remme WJ; Tavazzi L; Ferrari R;
    Eur Heart J; 2009 Jul; 30(13):1656-65. PubMed ID: 19406871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI.
    Pituskin E; Haykowsky M; Mackey JR; Thompson RB; Ezekowitz J; Koshman S; Oudit G; Chow K; Pagano JJ; Paterson I
    BMC Cancer; 2011 Jul; 11():318. PubMed ID: 21794114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of combination therapy with perindopril and losartan on left ventricular remodelling in patients with myocardial infarction.
    Li L; Liu RY; Zhao XY; Zhang JY; Jia M; Lu PQ
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):704-10. PubMed ID: 19207720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Remodeling with angiotensin-converting enzyme inhibitors: from GISSI to PREAMI].
    Nicolosi GL
    Ital Heart J; 2005 Nov; 6 Suppl 7():33S-39S. PubMed ID: 16485515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction.
    Mishra A; Srivastava A; Kumar S; Mittal T; Garg N; Agarwal SK; Pande S; Mittal B
    Indian Heart J; 2015; 67(3):214-21. PubMed ID: 26138177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.